Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-041171

Chief Commercial Officer acquired 147,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Piccina Cintia · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-03 Grant or award : show line 1 in the form +147,000 147,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +273,000 273,000 D
Loading xslF345X04/doc4.xml…